Question 1

Does Charles Schwab Investment Management own STLN stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Charles Schwab Investment Management holds 226,007 shares of STLN (Starling Oncology), worth $1.2M.

Question 2

How many shares of STLN does Charles Schwab Investment Management own?

Accepted Answer

As of its Q2 2026 13F, Charles Schwab Investment Management holds 226,007 shares of STLN (Starling Oncology).

Question 3

What is Charles Schwab Investment Management's STLN position worth?

Accepted Answer

As of its Q2 2026 13F, Charles Schwab Investment Management's STLN position is worth $1.2M.

Question 4

Is Charles Schwab Investment Management buying or selling STLN?

Accepted Answer

In Q2 2026, Charles Schwab Investment Management increased its STLN position by 11,092 shares (+5.2%).

Question 5

When did Charles Schwab Investment Management first buy STLN?

Accepted Answer

Charles Schwab Investment Management first reported STLN in its Q2 2022 13F and has listed it in 9 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	226,007	+5.2%	$1.2M	0.0%	$5.43	27
2026-Q1	Increased	214,915	+3.2%	$659,789	0.0%	$3.07	25
2025-Q4	Increased	208,265	+11.1%	$741,423	0.0%	$3.56	27
2025-Q3	Increased	187,534	+27.1%	$654,494	0.0%	$3.49	30
2025-Q2	New	147,534	-	$302,445	0.0%	$2.05	32
2023-Q2	Exited	0	-100.0%	$0	0.0%	$0.55	0
2023-Q1	Unchanged	87,594	0.0%	$59,380	0.0%	$0.68	0
2022-Q4	Unchanged	87,594	0.0%	$144,530	0.0%	$1.65	0
2022-Q3	Increased	87,594	+112.3%	$406,000	0.0%	$4.63	38
2022-Q2	New	41,261	-	$209,000	0.0%	$5.06	32

STLN10 quarters

STLN
10 quarters